Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
Transl Cancer Res
.
2020 Apr;9(4):2175-2177.
doi: 10.21037/tcr.2020.02.06.
Authors
Christoph Schulz
1
,
Sebastian Stintzing
2
Affiliations
1
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
2
Department of Hematology, Oncology and Tumor Immunology (CCM) Charité - Universitaetsmedizin Berlin, Berlin, Germany.
PMID:
35117577
PMCID:
PMC8797862
DOI:
10.21037/tcr.2020.02.06
No abstract available
Publication types
Editorial